Lilly’s experimental obesity pill holds up to scrutiny in trial

Eli Lilly & Co.’s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s competition with Novo Nordisk A/S.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup